Imke Christiaans

5.1k total citations
69 papers, 2.0k citations indexed

About

Imke Christiaans is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Imke Christiaans has authored 69 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cardiology and Cardiovascular Medicine, 19 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Imke Christiaans's work include Cardiomyopathy and Myosin Studies (43 papers), Cardiovascular Effects of Exercise (23 papers) and Viral Infections and Immunology Research (14 papers). Imke Christiaans is often cited by papers focused on Cardiomyopathy and Myosin Studies (43 papers), Cardiovascular Effects of Exercise (23 papers) and Viral Infections and Immunology Research (14 papers). Imke Christiaans collaborates with scholars based in Netherlands, United Kingdom and United States. Imke Christiaans's co-authors include Arthur A.M. Wilde, Irene M. van Langen, Erwin Birnie, Gouke J. Bonsel, J. Peter van Tintelen, Ronald H. Lekanne Deprez, Ellen M.A. Smets, Yigal M. Pinto, Frank Baas and Pepijn van den Munckhof and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and International Journal of Molecular Sciences.

In The Last Decade

Imke Christiaans

66 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Imke Christiaans Netherlands	25	1.5k	655	262	214	128	69	2.0k
Janneke Timmermans Netherlands	25	938 0.6×	373 0.6×	132 0.5×	955 4.5×	52 0.4×	53	2.0k
Allison L. Cirino United States	24	2.2k 1.5×	728 1.1×	306 1.2×	199 0.9×	8 0.1×	49	2.6k
Paolo Versacci Italy	22	321 0.2×	646 1.0×	493 1.9×	284 1.3×	18 0.1×	73	1.3k
Laura Yeates Australia	24	1.4k 1.0×	500 0.8×	254 1.0×	185 0.9×	6 0.0×	59	1.7k
Carmen Morales Spain	23	127 0.1×	284 0.4×	277 1.1×	337 1.6×	233 1.8×	69	1.4k
Kristian H. Mortensen United Kingdom	22	612 0.4×	435 0.7×	168 0.6×	860 4.0×	5 0.0×	55	1.7k
Neil Friedman United States	20	102 0.1×	242 0.4×	351 1.3×	121 0.6×	294 2.3×	59	1.2k
Kalliopi Pilichou Italy	27	2.9k 2.0×	371 0.6×	226 0.9×	104 0.5×	6 0.0×	82	3.2k
James B Lilleker United Kingdom	20	106 0.1×	281 0.4×	656 2.5×	68 0.3×	292 2.3×	77	1.1k
Ivan Macciocca Australia	16	407 0.3×	211 0.3×	60 0.2×	319 1.5×	5 0.0×	36	928

Countries citing papers authored by Imke Christiaans

Since Specialization

Citations

This map shows the geographic impact of Imke Christiaans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imke Christiaans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imke Christiaans more than expected).

Fields of papers citing papers by Imke Christiaans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imke Christiaans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imke Christiaans. The network helps show where Imke Christiaans may publish in the future.

Co-authorship network of co-authors of Imke Christiaans

This figure shows the co-authorship network connecting the top 25 collaborators of Imke Christiaans. A scholar is included among the top collaborators of Imke Christiaans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imke Christiaans. Imke Christiaans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jansen, M., Freyja H.M. van Lint, Laurens P. Bosman, et al.. (2024). Recreational and Occupational Physical Activity and Risk of Adverse Events in Truncating MYBPC3 Founder Variant Carriers. Circulation Genomic and Precision Medicine. 17(6). e004561–e004561. 2 indexed citations

Jansen, M., Remco de Brouwer, Amand F. Schmidt, et al.. (2023). Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies. JACC Heart Failure. 12(1). 134–147. 9 indexed citations

Jansen, M., Amand F. Schmidt, Judith Jans, et al.. (2023). Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers. Journal of Cardiovascular Translational Research. 16(6). 1267–1275. 4 indexed citations

Jansen, M., Maike Schuldt, Amand F. Schmidt, et al.. (2023). Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants. International Journal of Molecular Sciences. 24(4). 4031–4031. 9 indexed citations

Bootsma, Marianne, Chai‐Ann Ng, Arthur A.M. Wilde, et al.. (2022). Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetrance. Human Molecular Genetics. 32(7). 1072–1082. 2 indexed citations

Jansen, M., Imke Christiaans, Saskia N. van der Crabben, et al.. (2021). BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status. Netherlands Heart Journal. 29(6). 318–329. 6 indexed citations

Hoedemaekers, Yvonne M., Annette F. Baas, Marieke J.H. Baars, et al.. (2021). A tailored approach to informing relatives at risk of inherited cardiac conditions: results of a randomised controlled trial. European Journal of Human Genetics. 30(2). 203–210. 14 indexed citations

Maeckelberghe, Els, et al.. (2021). A genetic researcher’s devil’s dilemma: Warn relatives about their genetic risk or respect confidentiality agreements with research participants?. BMC Medical Ethics. 22(1). 155–155. 3 indexed citations

Post, Marco C., Jasper J. van der Smagt, Frances S. de Man, et al.. (2020). Genetic Evaluation in a Cohort of 126 Dutch Pulmonary Arterial Hypertension Patients. Genes. 11(10). 1191–1191. 26 indexed citations

10.

Langen, Irene M. van, et al.. (2020). Long-Term Follow-Up Study on the Uptake of Genetic Counseling and Predictive DNA Testing in Inherited Cardiac Conditions. Circulation Genomic and Precision Medicine. 13(5). 524–530. 12 indexed citations

11.

Hoedemaekers, Yvonne M., et al.. (2019). A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial. BMJ Open. 9(7). e025660–e025660. 3 indexed citations

12.

Zelst–Stams, Wendy A.G. van, et al.. (2019). How to inform at‐risk relatives? Attitudes of 1379 Dutch patients, relatives, and members of the general population. Journal of Genetic Counseling. 29(5). 786–799. 25 indexed citations

13.

Alders, Mariëlle, Hennie Bikker, & Imke Christiaans. (2015). Long QT Syndrome. 13 indexed citations

14.

Postema, Pieter G., S. Matthijs Boekholdt, Hanno L. Tan, et al.. (2015). Detailed characterization of familial idiopathic ventricular fibrillation linked to the DPP6 locus. Heart Rhythm. 13(4). 905–912. 32 indexed citations

15.

Milano, Annalisa, Alexa M.C. Vermeer, Elisabeth M. Lodder, et al.. (2014). HCN4 Mutations in Multiple Families With Bradycardia and Left Ventricular Noncompaction Cardiomyopathy. Journal of the American College of Cardiology. 64(8). 745–756. 126 indexed citations

16.

Spaendonck‐Zwarts, Karin Y. van, Ingrid A.W. van Rijsingen, Maarten P. van den Berg, et al.. (2013). Genetic Analysis in 418 Index Patients with Idiopathic Dilated Cardiomyopathy: Overview of 10 Years’ Experience. European Journal of Heart Failure. 15(6). 628–636. 114 indexed citations

17.

Christiaans, Imke, Phil Barnett, Ronald H. Lekanne Deprez, et al.. (2012). A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(4). 833–839. 15 indexed citations

18.

Timmer, Stefan A.J., Tjeerd Germans, Wessel P. Brouwer, et al.. (2011). Carriers of the Hypertrophic Cardiomyopathy MYBPC3 Mutation are Characterized by Reduced Myocardial Efficiency in the Absence of Hypertrophy and Microvascular Dysfunction. European Journal of Heart Failure. 13(12). 1283–1289. 48 indexed citations

19.

Christiaans, Imke, Theo A.M. van Os, Frank Baas, et al.. (2010). Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas. Journal of Medical Genetics. 48(2). 93–97. 105 indexed citations

20.

Christiaans, Imke, et al.. (2004). [No spectacular rise in claims for medical damages in The Netherlands: 1993-'01 compared to 1980-'90].. PubMed. 148(25). 1250–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact